COVIPACT - Impact of the COVID-19 epidemic on patient management in the oncology-haematology setting, and on psychological repercussions among patients and caregivers
Head :
FAVEYRIAL Audrey
Last update : 04/30/2021 | Version : 1 | ID : 73892
| General | |
| Identification | |
| Detailed name | Impact of the COVID-19 epidemic on patient management in the oncology-haematology setting, and on psychological repercussions among patients and caregivers |
| Sign or acronym | COVIPACT |
| General Aspects | |
| Medical area |
Cancer research |
| Study in connection with Covid-19 |
Yes |
| Pathology (details) | CANCER |
| Health determinants |
Lifestyle and behavior |
| Scientific investigator(s) (Contact) | |
| Name of the director | FAVEYRIAL |
| Surname | Audrey |
| Address | CENTRE FRANCOIS BACLESSE - CAEN |
| Phone | 231455050 |
| a.faveyrial@baclesse.unicancer.fr | |
| Organization | FRANCOIS BACLESSE CENTRE |
| Collaborations | |
| Participation in projects, networks and consortia |
No |
| Funding | |
| Governance of the database | |
| Sponsor(s) or organisation(s) responsible | FRANCOIS BACLESSE CENTRE |
| Organisation status |
Both |
| Presence of scientific or steering committees |
No |
| Additional contact | |
| Name of the contact | LECONTE |
| Surname | Alexandra |
| Address | 3 avenue du Général Harris - 14076 CAEN cedex |
| a.leconte@baclesse.unicancer.fr | |
| Organization | François Baclesse Centre |
| Main features | |
| Type of database | |
| Type of database |
Others |
| Specify | data obtained from medical records |
| Study databases (details) |
Cohort study |
| Database recruitment is carried out by an intermediary |
A selection of health institutions and services |
| Database recruitment is is made on the basis of: |
Another treatment or procedure |
| Database recruitment is carried out as part of an interventional study |
No |
| Additional information regarding sample selection. | Recruitment of patients and healthcare professionals |
| Database objective | |
| Main objective | Evaluate the impact of the COVID-19 pandemic on adjustments to medical cancer treatment delivered in the outpatient setting to patients with cancer or haematological malignancies undergoing treatment. |
| Inclusion criteria |
- Adult patient, treated for a solid tumour or haematological malignancy
- Receiving or needing to receive medical cancer treatment delivered in an outpatient oncology setting at participating sites: treatment initiated before or during the COVID-19 pandemy - The patient does not object to taking part in the study - Patient not deprived of their liberty or under supervision - Female patient with no associated geographical, social or psychopathological condition liable to compromise the patient’s ability to take part in the study |
| Population type | |
| Age |
Adulthood (19 to 24 years) Adulthood (25 to 44 years) Adulthood (45 to 64 years) Elderly (65 to 79 years) Great age (80 years and more) |
| Population covered |
Sick population |
| Pathology | C00-C97 - Malignant neoplasms |
| Gender |
Male Woman |
| Geography area |
Regional |
| French regions covered by the database |
Normandie |
| Data collection | |
| Dates | |
| Date of first collection (YYYY or MM/YYYY) | 2020 |
| Date of last collection (YYYY or MM/YYYY) | 2021 |
| Size of the database | |
| Size of the database (number of individuals) |
[500-1000[ individuals |
| Details of the number of individuals | 808 |
| Data | |
| Database activity |
Current data collection |
| Type of data collected |
Clinical data |
| Clinical data (detail) |
Direct physical measures |
| Presence of a biobank |
No |
| Procedures | |
| Participant monitoring |
Yes |
| Monitoring procedures |
Monitoring by contact with the participant (mail, e-mail, telephone etc.) |
| Links to administrative sources |
No |
| Promotion and access | |
| Promotion | |
| Access |
